<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04492748</url>
  </required_header>
  <id_info>
    <org_study_id>SMC2020001</org_study_id>
    <nct_id>NCT04492748</nct_id>
  </id_info>
  <brief_title>Rotator Cuff Tendinopathy Conservative Treatment With Collagen, PRP or Both</brief_title>
  <acronym>RCCT</acronym>
  <official_title>Collagen and PRP in Partial Thickness Rotator Cuff Injuries: Friends or Only Indifferent Neighbors: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sutherland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sutherland Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the trial is comparison of the effectiveness of three methods of conservative&#xD;
      treatment in partial thickness rotator cuff injury (PTRCI): collagen with PRP injections, PRP&#xD;
      injections alone and collagen injections alone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Rotator cuff injury (RCI) occupy third place in the population among the&#xD;
      musculoskeletal system pathologies (16%) after low back pain (25%) and knee pain (19%).&#xD;
      Partial thickness RCI (PTRCI) is the sum of degenerative, overload and microtrauma processes&#xD;
      and their incidence increases significantly with age (up to 30% over 60). One of the factors&#xD;
      contributing to the injury is a negative collagen balance and slowed tendon metabolism in&#xD;
      proportion to its blood supply disorders. Conservative treatment of PTRCI of degenerative&#xD;
      origin is the first choice management, but there are no clear guidelines. External supply of&#xD;
      collagen and PRP could potentially counteract these processes.&#xD;
&#xD;
      AIM: Comparison of the effectiveness of three treatment concepts: collagen with PRP, PRP&#xD;
      alone, collagen alone in the treatment of PTRCI.&#xD;
&#xD;
      DESIGN: Randomized prospective trial without blinding SETTING: Open study for outpatients,&#xD;
      single center study POPULATION: local population METHODS: Three groups of patients (each&#xD;
      group 30 patients) with PTRCI confirmed by ultrasound (N=90). The assessment of the&#xD;
      supraspinatus tendon (SSP) in standard position of internal rotation of the upper limb for&#xD;
      ultrasound examination, assessment of the thickness of the RC in cross-section (mm). Each&#xD;
      group treated by three ultrasound guided injections into the shoulder bursa every consecutive&#xD;
      week: Group A - collagen (3 amp Collagen MD Shoulder) together with PRP (2ml); Group B -&#xD;
      collagen alone (3 amp Collagen MD Shoulder); Group C - PRP alone. All patients were allowed&#xD;
      to continue rehabilitation protocol. Primary control tools: NRS, QuickDash, EQ-5D-5L in&#xD;
      control points: IA (initial assessment), 6, 12 and 24 weeks after last injection. Secondary&#xD;
      control tools: percentage of patients where the RC continuity were preserved and percentage&#xD;
      of patients who had ultrasonographic signs of RC regeneration (crossection width increase,&#xD;
      improvement of echogenicity) during the observation period between W0 and 24 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in EQ-5D-5L index from baseline to 24 week</measure>
    <time_frame>Change from baseline to 24 weeks</time_frame>
    <description>EQ-5D-5L index estimated from EQ-5D-5L desrcriptive system based on Polish directly measured value set. Mininmum: -0.590; Maximum: 1.0; More points means better outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>QuickDASH (Disabilities of Arm, Shoulder and Hand) questionnaire summary score change from baseline to 24 weeks</measure>
    <time_frame>Change from baseline to 24 weeks</time_frame>
    <description>Range: 0 (the best outcome) - 100 (the worst outcome).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain according to Numeric Rating Scale (NRS)</measure>
    <time_frame>Change from baseline to 6 weeks</time_frame>
    <description>0 (no pain) - 10 points (the worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain according to Numeric Rating Scale (NRS)</measure>
    <time_frame>Change from baseline to 12 weeks</time_frame>
    <description>0 (no pain) - 10 points (the worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain according to Numeric Rating Scale (NRS)</measure>
    <time_frame>Change from baseline to 24 weeks</time_frame>
    <description>0 (no pain) - 10 points (the worst possible pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Width of rotator cuff in ultrasound imaging</measure>
    <time_frame>Change from baseline to 24 weeks</time_frame>
    <description>Dimensions of cross-section rotator cuff measure in milimeters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preservation of rotator cuff continuity in ultrasound imaging</measure>
    <time_frame>Change from baseline to 24 weeks</time_frame>
    <description>Presence / Absence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regenaration of rotator cuff in ultrasound imaging</measure>
    <time_frame>24 weeks</time_frame>
    <description>Presence / Absence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EQ-5D-5L index from baseline to 6 week</measure>
    <time_frame>Change from baseline to 6 weeks</time_frame>
    <description>EQ-5D-5L index estimated from EQ-5D-5L desrcriptive system based on Polish directly measured value set. Mininmum: -0.590; Maximum: 1.0; More points means better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in EQ-5D-5L index from baseline to 12 week</measure>
    <time_frame>Change from baseline to 12 weeks</time_frame>
    <description>EQ-5D-5L index estimated from EQ-5D-5L desrcriptive system based on Polish directly measured value set. Mininmum: -0.590; Maximum: 1.0; More points means better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QuickDASH (Disabilities of Arm, Shoulder and Hand) questionnaire summary score change from baseline to 6 weeks</measure>
    <time_frame>Change from baseline to 6 weeks</time_frame>
    <description>Range: 0 (the best outcome) - 100 (the worst outcome).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QuickDASH (Disabilities of Arm, Shoulder and Hand) questionnaire summary score change from baseline to 12 weeks</measure>
    <time_frame>Change from baseline to 12 weeks</time_frame>
    <description>Range: 0 (the best outcome) - 100 (the worst outcome).</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Rotator Cuff Tendinosis</condition>
  <condition>Rotator Cuff Tears</condition>
  <arm_group>
    <arm_group_label>Collagen and PRP injections</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided injections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Collagen injections</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided injections</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRP injections</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided injections</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Collagen and platelet rich plasma (PRP)</intervention_name>
    <description>Ultrasound guided injections</description>
    <arm_group_label>Collagen and PRP injections</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Collagen</intervention_name>
    <description>Ultrasound guided injections</description>
    <arm_group_label>Collagen injections</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Platelet rich plasma (PRP)</intervention_name>
    <description>Ultrasound guided injections</description>
    <arm_group_label>PRP injections</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  clinical signs and symptoms of rotator cuff pathology&#xD;
&#xD;
          -  an adult person consenting to injections&#xD;
&#xD;
          -  partial thickness rotator cuff injury confirmed by ultrasound examination without&#xD;
             coexisting severe pathologies (systemic inflammatory disease, malignancy, severe stage&#xD;
             OA)&#xD;
&#xD;
          -  no traumatic event&#xD;
&#xD;
          -  no injections or any other local treatment in previous 1 month&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  full thickness rotator cuff injury&#xD;
&#xD;
          -  acute, traumatic injuries requiring surgical treatment&#xD;
&#xD;
          -  coexisting injuries of the shoulder joint requiring other intervention&#xD;
&#xD;
          -  severe pathologies of the shoulder of another origin (systemic inflammatory disease,&#xD;
             malignancy, severe stage OA)&#xD;
&#xD;
          -  no consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Piotr Godek, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sutherland Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sutherland Medical Center</name>
      <address>
        <city>Warsaw</city>
        <state>Mazowieckie</state>
        <zip>04-036</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>July 20, 2020</study_first_submitted>
  <study_first_submitted_qc>July 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2020</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sutherland Medical Center</investigator_affiliation>
    <investigator_full_name>Piotr Godek</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
    <mesh_term>Rotator Cuff Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

